 LYON, France and CAMBRIDGE, Mass., Dec. 10, 2020 GLOBE NEWSWIRE -- ERYTECH Pharma Nasdaq Euronext: ERYP, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announce d today that CEO, Gil Beyen, will present at t he JMP Securities Hematology Summit Tuesday December 15 th at 1: 3 0pm EST 0 6 : 3 0pm GMT 7 : 3 0pm CET . The format will be a fireside chat discussion hosted by JMP Securities Reni Benjamin. 